Skip to content

Pharma and healthcare: sector news on Wednesday 18 November 2026

Average tone +5.7 (positive) across 5 companies with relevant coverage, from 76 stories.

How to read a score. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.

Company by company

CompanyToneStoriesWhat the coverage was about
GSK+7.536Most coverage focused on US approval of Nelkarmi, the second lung cancer medicine to come from the Nuvalent acquisition, which advances its oncology push.
AstraZeneca+7.029Coverage was mostly positive, centred on new US and EU approvals including Klygefa, a dismissed antitrust lawsuit and a Jefferies price target increase.
Haleon+4.56Coverage focused on Haleon's push into India through low-priced packs and an Otrivin awareness campaign, plus a director buying shares with her own money.
Smith & Nephew+4.83Coverage focused on Smith & Nephew's simpler strategy, alongside commentary on its last buyback tranche and its appeal as a watchlist name.
Convatec+4.72Coverage centred on the appointment of a new chief financial officer from Fortrea, alongside commentary on whether the company can deliver on its plans.

Strongest stories in the sector

Pharma and healthcare: every day · FTSE 100 overview for the day

Follow by email

A short, free morning email on how the news treated the Pharma and healthcare sector: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.

How it works. Every morning an AI model reads the UK business news about each FTSE 100 company and scores how good or bad it is for the company, from −10 to +10. Pages update by about 07:45 UK time.

Not investment advice. MarketFrame rates the tone of news coverage. It is general information, not a recommendation to buy or sell anything. The scores are not share-price data or forecasts: a good score doesn't mean a share will rise, and a bad one doesn't mean it will fall.

Data to 06:30 UTC, 18 November · 867 headlines · 94 companiesMade by Adapt Progress Evolve Limited, a UK company · Privacy · Terms · Who we are · RSS · API · llms.txt